Greg A Kirchenbaum Selected Research

Antibodies

11/2021	A Competitive Hemagglutination Inhibition Assay for Dissecting Functional Antibody Activity against Influenza Virus.
1/2021	Affinity Tag Coating Enables Reliable Detection of Antigen-Specific B Cells in Immunospot Assays.
1/2021	Deconvoluting the T Cell Response to SARS-CoV-2: Specificity Versus Chance and Cognate Cross-Reactivity.
1/2021	Impaired memory B-cell recall responses in the elderly following recurrent influenza vaccination.
1/2020	Preexisting subtype immunodominance shapes memory B cell recall response to influenza vaccination.
1/2018	Elicitation of Broadly Protective Antibodies following Infection with Influenza Viruses Expressing H1N1 Computationally Optimized Broadly Reactive Hemagglutinin Antigens.
12/2017	Elicitation of Protective Antibodies against a Broad Panel of H1N1 Viruses in Ferrets Preimmune to Historical H1N1 Influenza Viruses.
1/2016	Sequential Infection in Ferrets with Antigenically Distinct Seasonal H1N1 Influenza Viruses Boosts Hemagglutinin Stalk-Specific Antibodies.
6/2014	Eliciting broadly protective antibody responses against influenza.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Greg A Kirchenbaum Research Topics

Disease

14	Human Influenza (Influenza) 01/2024 - 06/2014
7	Infections 11/2021 - 06/2014
4	COVID-19 01/2024 - 01/2021
1	Neoplasms (Cancer) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Common Cold 01/2021
1	Reinfection 01/2021
1	Communicable Diseases (Infectious Diseases) 01/2019
1	Job Syndrome (Hyper-IgE Syndrome) 01/2015
1	Influenza in Birds (Avian Flu) 01/2015

Drug/Important Bio-Agent (IBA)

9	AntibodiesIBA 11/2021 - 06/2014
8	Influenza Vaccines (Influenza Vaccine)FDA Link 11/2021 - 06/2014
7	VaccinesIBA 01/2020 - 06/2014
5	AntigensIBA 11/2022 - 01/2018
5	Hemagglutinins (Hemagglutinin)IBA 01/2021 - 06/2014
3	Proteins (Proteins, Gene)FDA Link 12/2017 - 06/2014
2	Glycoproteins (Glycoprotein)IBA 01/2021 - 12/2017
1	Neutralizing AntibodiesIBA 01/2024
1	Messenger RNA (mRNA)IBA 01/2024
1	Monophenol Monooxygenase (Tyrosinase)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 08/2020
1	Interleukin-4 (Interleukin 4)IBA 01/2020
1	interleukin-21 (interleukin 21)IBA 01/2020
1	Interleukin-2 (IL2)IBA 01/2020
1	Viral AntigensIBA 12/2017
1	Viral RNAIBA 10/2015
1	Immunoglobulin E (IgE)IBA 01/2015
1	AutoantibodiesIBA 01/2015